parameter

EFS at 3-ys

95% CI

P-value

OS at 3-ys

95% CI

P-value

Whole patients

45.7%

36.9% - 56.7%

66.7%

57% - 77.8%

Stage

- I

- III

- IV

100%

53.2%

17.8%

42.6% - 66.4%

8.1% - 39.3%

<0.001

100%

74.7%

23.9%

64.4% - 86.6%

5.6% - 100%

<0.001

Histology

- PFH

- Combined

(Fetal & Embry)

- Mixed

(Epi & mesen)

51%

50.8%

55.5%

36.7% - 70.6%

33.3% - 77.4%

39.5% - 78%

0.85

81.3%

70%

64%

70.3% - 94%

51% - 94.8%

46% - 89%

0.5

Metastasis

- Yes

- No

18.5%

54.8%

8.4% - 40.5%

44.5% - 67.5%

<0.001

24.8%

75.2%

5.8% - 100%

65.4% - 86.5%

<0.001

AFP level

- Above 100

- Below 100

48.3 %

28.6%

0.1

69 %

38%

0.02

Surgery

- Yes

- No

68.6%

58% - 81.2%

<0.001

80.7%

70.6% - 92.2%

<0.001

Risk group

- LR

- IR

- HR

100%

55.6%

19.4%

<0.001

100%

75.3%

37.4%

0.001